Safety, feasibility and trends of efficacy of intravenous injection of autologous adipose-derived mesenchymal stromal cells in patients with amyotrophic lateral sclerosis: A phase I-IIa multicenter randomized triple blind placebo controlled trial

被引:0
|
作者
Lora, F. [1 ]
Fernandez, O. [3 ]
Aguera, E. [2 ]
Fernandez, V. E. [3 ]
Reyes, V. [3 ]
Navarro, G. [4 ]
Cabezas, J. A. [5 ]
Pena, M. A. [3 ]
Leyva, L. [6 ]
Macias, M. [1 ]
Garcia-Vinuesa, A. [1 ]
Mata, R. [1 ]
机构
[1] Andalusian Network Design & Translat Adv Therapie, Seville, Spain
[2] Reina Sofia Hosp, Cordoba, Spain
[3] Reg Univ Hosp Malaga, Malaga, Spain
[4] Virgen Macarena Univ Hosp, Seville, Spain
[5] Virgen del Rocio Univ Hosp, Seville, Spain
[6] Reg Univ Hosp Malaga IBIMA, Cell Mfg Unit, GMP Network, Andalusian Initiat Adv Therapies, Malaga, Spain
关键词
D O I
暂无
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
P674
引用
收藏
页码:A212 / A212
页数:1
相关论文
共 50 条
  • [1] Safety, Feasibility of Intravenous and Intrathecal Injection of Autologous Bone Marrow Derived Mesenchymal Stromal Cells in Patients with Amyotrophic Lateral Sclerosis: An Open Label Phase I Clinical Trial
    Nabavi, Seyed Massood
    Arab, Leila
    Jarooghi, Neda
    Bolurieh, Tina
    Abbasi, Fatemeh
    Mardpour, Soura
    Azimyian, Vajihe
    Moeininia, Fatemeh
    Maroufizadeh, Saman
    Sanjari, Leila
    Hosseini, Seyedeh Esmat
    Aghdami, Nasser
    CELL JOURNAL, 2019, 20 (04) : 592 - 598
  • [2] Transplantation of Mesenchymal Stromal Cells in Patients With Amyotrophic Lateral Sclerosis: Results of Phase I/IIa Clinical Trial
    Sykova, Eva
    Rychrnach, Petr
    Drahoradova, Ivana
    Konradova, Simona
    Ruzickova, Katerina
    Vorisek, Ivan
    Forostyak, Serhiy
    Homola, Ales
    Bojar, Martin
    CELL TRANSPLANTATION, 2017, 26 (04) : 647 - 658
  • [3] Clinical Efficacy and Safety of the Intra-articular Injection of Autologous Adipose-Derived Mesenchymal Stem Cells for Knee Osteoarthritis: A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial
    Kim, Kang-Il
    Lee, Myung Chul
    Lee, Ju Hong
    Moon, Young-Wan
    Lee, Woo-Suk
    Lee, Han-Jun
    Hwang, Sun-Chul
    In, Yong
    Shon, Oog-Jin
    Bae, Ki-Cheor
    Song, Sang-Jun
    Park, Kwan Kyu
    Kim, Jun-Ho
    AMERICAN JOURNAL OF SPORTS MEDICINE, 2023, 51 (09): : 2243 - 2253
  • [4] Safety and efficacy of autologous, adipose-derived mesenchymal stem cells in patients with rheumatoid arthritis: a phase I/IIa, open-label, non-randomized pilot trial
    Ridhima Vij
    Kevin A. Stebbings
    Hosu Kim
    Hyeonggeun Park
    Donna Chang
    Stem Cell Research & Therapy, 13
  • [5] Safety and efficacy of autologous, adipose-derived mesenchymal stem cells in patients with rheumatoid arthritis: a phase I/IIa, open-label, non-randomized pilot trial
    Vij, Ridhima
    Stebbings, Kevin A.
    Kim, Hosu
    Park, Hyeonggeun
    Chang, Donna
    STEM CELL RESEARCH & THERAPY, 2022, 13 (01)
  • [6] Adipose-derived mesenchymal stem cells (AdMSC) for the treatment of secondary-progressive multiple sclerosis: A triple blinded, placebo controlled, randomized phase I/II safety and feasibility study
    Fernandez, Oscar
    Izquierdo, Guillermo
    Fernandez, Victoria
    Leyva, Laura
    Reyes, Virginia
    Guerrero, Miguel
    Leon, Antonio
    Arnaiz, Carlos
    Navarro, Guillermo
    Dolores Paramo, Maria
    De la Cuesta, Antonio
    Soria, Bernet
    Hmadcha, Abdelkrim
    Pozo, David
    Fernandez-Montesinos, Rafael
    Leal, Maria
    Ochotorena, Itziar
    Galvez, Patricia
    Angeles Geniz, Maria
    Javier Baron, Francisco
    Mata, Rosario
    Medina, Cristina
    Caparros-Escudero, Carlos
    Cardesa, Ana
    Cuende, Natividad
    PLOS ONE, 2018, 13 (05):
  • [7] Efficacy of mecasin for treatment of amyotrophic lateral sclerosis: A phase IIa multicenter randomized double-blinded placebo-controlled trial
    Kim, Sungha
    Yang, Muhack
    Ku, Boncho
    Cha, Eunhye
    Seo, Wookcheol
    Son, Ilhong
    Kang, Hyungwon
    Kim, Dongwoung
    Song, Bongkeun
    Yang, Chang-Sop
    Kim, Sungchul
    JOURNAL OF ETHNOPHARMACOLOGY, 2023, 315
  • [8] Intravenous transplantation of bone marrow-derived mesenchymal stromal cells in patients with multiple sclerosis, a phase I/IIa, double blind, randomized controlled study
    Nabavi, Seyed Massood
    Karimi, Shahedeh
    Arab, Leila
    Aghdami, Nasser
    Joghtaei, Neda
    Maroufizadeh, Saman
    Jarooghi, Neda
    Bolurieh, Tina
    Abbasi, Fatemeh
    Mardpour, Soura
    Azimyian, Vajihe
    Moeininia, Fatemeh
    Sanjari, Leila
    Hosseini, Seyedeh Esmat
    Vosough, Massoud
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2023, 78
  • [9] Safety and feasibility of autologous adipose-derived stromal vascular fraction in the treatment of keloids: a phase one randomized controlled pilot trial
    Mbiine, Ronald
    Kayiira, Anthony
    Wayengera, Misaki
    Guyton, Munabi Ian
    Kiwanuka, Noah
    Alenyo, Rose
    Kalanzi, Edris Wamala
    Muwonge, Haruna
    Nakanwagi, Cephas
    Joloba, Moses
    Galukande, Moses
    AMERICAN JOURNAL OF STEM CELLS, 2023, 12 (02): : 23 - 36
  • [10] Phase I Trial of Repeated Intrathecal Autologous Bone Marrow-Derived Mesenchymal Stromal Cells in Amyotrophic Lateral Sclerosis
    Oh, Ki-Wook
    Moon, Chanil
    Kim, Hyun Young
    Oh, Sung-Il
    Park, Jinseok
    Lee, Jun Ho
    Chang, In Young
    Kim, Kyung Suk
    Kim, Seung Hyun
    STEM CELLS TRANSLATIONAL MEDICINE, 2015, 4 (06) : 590 - 597